The Latest Cardiac and Vascular News
NEW BRUNSWICK, N.J. – April 24, 2026 – Johnson & Johnson (NYSE: JNJ) has entered into a definitive agreement to acquire Atraverse Medical, Inc., a privately-held medical device company pioneering next-generation left-heart access and radiofrequency (RF) technology. Achieving safe and precise access to the left atrium remains one of the most critical steps […]
SAN DIEGO, Feb. 9, 2026 /PRNewswire/ — Atraverse Medical today announced the presentation of new clinical and preclinical data at AF Symposium 2026 in Boston, further validating the safety, performance, and workflow advantages of the company’s HOTWIRE™ Transseptal Access System. Findings…
Atraverse Medical also approaches first 2,000 successful clinical procedures using the company’s innovative HOTWIRE™ radiofrequency (RF) guidewire. [San Diego, CA – December 3, 2025] — Atraverse Medical, a medical device company pioneering next-generation left-heart access technology, has received 510(k) clearance from the U.S. FDA for its fully integrated HOTWIRE™ Transseptal […]
Proceeds will be used to grow the commercial organization, scale-up manufacturing operations, and launch additional products in the R&D pipeline. [San Diego, CA – June 10, 2025] Atraverse Medical, a medical device company pioneering next-generation transseptal access technology, today announced the close of a $29.4 million follow-on financing to accelerate […]
SAN DIEGO, July 30, 2024 /PRNewswire/ — The HOTWIRE™ RF guidewire device by Atraverse Medical, a San Diego-based medical device company, has been used for the first time in clinical practice by world-renowned cardiac electrophysiologist, Dr. Devi Nair, at St. Bernards Medical Center. The…
